The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩6,560.46Fair value₩14,131.47Bull₩42,550.67
FairClose
52-week traded range
52W low ₩9,950.0052W high ₩13,250.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
AHN-GOOK PHARMACEUTICAL Co., Ltd. closed at ₩10,160.00, 28.1% below the consensus fair value of ₩14,131.47 drawn from 10 valuation models.
Financial DNA score 53/100 — Good. P/E of 15.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩13,060.65
+28.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩14,658.92
+44.3%
√(22.5 × EPS × BVPS)
EPS=658, BVPS=14514.29
Graham Formula
₩42,550.67
+318.8%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=20%, FD=3.3%
P/E Fair Value
₩13,160.00
+29.5%
EPS × 20x (sector P/E)
EPS=658, Sector P/E=20x
Peter Lynch (PEG)
₩14,956.34
+47.2%
EPS × Growth% (PEG = 1 is fair)
EPS=658, g=22.7%
EV/EBITDA
₩9,378.31
-7.7%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=9.82B
Dividend Discount (DDM)
₩38,404.80
+278.0%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=711.2, r=10%, g=8%
Book Value (P/B)
₩6,560.46
-35.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=14514.29, ROE=4.5%, g=6%, r=10%
Reverse DCF
₩10,160.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 3.7% | Historical: 22.7%
Margin of Safety
₩15,643.17
+54.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=20857.56, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.